KLRK1 and hematologic disorder: Furthermore, hypoxia downregulates NKp30, NKp44, NKp46, NKG2D, perforin, and granzyme B. Treatment with IL-2 has been shown to restore NK cell cytotoxicity by increasing NKG2D in some hematological malignancies (133).